Video Experimental Relacionado
Updated: Aug 14, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Bacterioterapia para la diarrea por Clostridium difficile con recaídas crónicas en seis pacientes
1Department of Clinical Microbiology, Rigshospitalet, Statens Seruminstitut, Denmark.
Lancet (London, England)
|May 27, 1989
Resumen
La restauración de las bacterias intestinales beneficiosas, específicamente las especies Bacteroides, puede tratar eficazmente la diarrea crónica causada por Clostridium difficile. Este enfoque de trasplante de microbiota fecal restablece un microbioma intestinal saludable, evitando las infecciones recurrentes por C. difficile.
Área de la Ciencia:
- Microbiología Microbiología.
- Gastroenterología y Gastroenterología.
- Enfermedades infecciosas Enfermedades infecciosas.
Sus antecedentes:
- La diarrea recurrente crónica a menudo es causada por una infección por Clostridium difficile.
- El papel de bacterias intestinales específicas en la prevención de la recurrencia de C. difficile no se entiende completamente.
Objetivo del estudio:
- Investigar la eficacia del trasplante de microbiota fecal en el tratamiento de la diarrea crónica recidivante por Clostridium difficile.
- Para identificar las especies bacterianas específicas involucradas en el efecto terapéutico.
Principales métodos:
- Instilación rectal de heces homólogas o una mezcla bacteriana definida en seis pacientes.
- Análisis de heces para Clostridium difficile, su toxina y composición bacteriana antes y después del tratamiento.
- Estudios in vitro para evaluar las interacciones bacterianas.
Principales resultados:
- El tratamiento con una mezcla bacteriana condujo a la pronta eliminación de C. difficile y su toxina.
- Se observó una colonización exitosa por especies de Bacteroides después del tratamiento.
- Las pruebas in vitro mostraron efectos inhibidores de ciertas bacterias en el crecimiento de C. difficile.
Conclusiones:
- La ausencia de especies de Bacteroides puede predisponer a las personas a la diarrea crónica recidivante de C. difficile.
- La restauración de las especies de Bacteroides a través del trasplante de microbiota fecal puede prevenir la colonización y la recurrencia de C. difficile.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...